Health Care Market News Psychedelics " Revive Therapeutics (CSE:RVV) & PharmaTher (CSE:PHRM) sign MDMA research collaboration agreement Revive Therapeutics (RVV), and PharmaTher (PHRM) have signed a research collaboration agreement. Jon Brown2 mins03 February 2023 12:15 (EST)124
Market News Psychedelics " Field Trip Health & Wellness (TSXV:FTHW) begins trading on the OTC Market Field Trip Health & Wellness (FTHW) has received approval to start trading on the OTCQB Market in the United States. Azuka Onwuka2 mins03 February 2023 09:00 (EST)83
Cannabis Health Care Psychedelics The Market Herald Deal Room " Irwin Naturals (CSE:IWIN) secures $40 million financing Irwin Naturals (IWIN) has secured a credit facility with its existing commercial lender for up to $60 million. Azuka Onwuka2 mins02 February 2023 09:25 (EST)106
Health Care Market News Psychedelics " Numinus (TSX:NUMI) receives Health Canada approval for psychedelic tea therapy Numinus Wellness (NUMI) has received approval from Health Canada for its experiential training study. Caroline Egan2 mins01 February 2023 13:15 (EST)73
Health Care Market News Psychedelics " Small Pharma (TSXV:DMT) adds two new patents to its portfolio approved for issue Small Pharma (DMT) has had two patents approved by the U.S. Patent & Trademark Office to further build up its portfolio. Jon Brown2 mins01 February 2023 13:00 (EST)90
Market News Psychedelics " Psyched Wellness (CSE:PSYC) adds new bottle size for Amanita Muscaria Extract Calm Psyched Wellness (PSYC) will launch a new larger bottle size for their Amanita Muscaria Extract (AME-1) product Calm on February 28th. Shoran Devi1 min01 February 2023 10:00 (EST)76
Health Care Market News Psychedelics " Cybin (NEO:CYBN) announces first-in-human dosing of its DMT molecule Cybin (CYBN) will initiate the first-in-human dosing of its proprietary deuterated DMT molecule, CYB004. Trevor Abes2 mins01 February 2023 09:30 (EST)65
Health Care Market News Psychedelics " Irwin Naturals (CSE:IWIN) signs LOI to acquire Braxia Scientific (CSE:BRAX) Irwin Naturals Inc. (IWIN) has signed an amended LOI to acquire medical and psychedelic research company Braxia Scientific Corp. (BRAX). Caroline Egan2 mins30 January 2023 11:45 (EST)92
Cannabis Consumer Market News Psychedelics " Irwin Naturals (CSE:IWIN) to distribute cannabis products in Oklahoma Irwin Naturals (IWIN) has signed a licensing agreement with Gold Rush Premium Extracts to produce and distribute THC products in Oklahoma. Caroline Egan2 mins26 January 2023 15:00 (EST)98
Health Care Market News Psychedelics " Lobe Sciences (CSE:LOBE) signs agreement with Integrative Headache Medicine of New York Lobe Sciences Limited (LOBE) has signed an Investigator Initiated Research Agreement with Lauren R. Natbony, MD, FAHS. Azuka Onwuka2 mins26 January 2023 13:15 (EST)72
Consumer Market News Psychedelics " Red Light Holland (CSE:TRIP) updates on Peterborough mushroom farm Ontario-based mushroom producer Red Light Holland Corp. (TRIP) has provided an update on its Caroline Egan2 mins24 January 2023 15:30 (EST)124
Market News Psychedelics " Psyched Wellness (CSE:PSYC) launches eCommerce fulfillment with ShipHero8 Psyched Wellness (PSYC) has officially launched with fulfillment partner ShipHero. John Ballem2 mins24 January 2023 11:45 (EST)61
Market News Psychedelics " Psyence (CSE:PSYG) exports pharma-grade psilocybin extract to the U.K. Psyence (PSYG) has exported purified pharmaceutical-grade psilocybin mushroom extract to its contract development & manufacturing organization partner in the U.K. Jon Brown2 mins20 January 2023 11:45 (EST)171
Health Care Market News Psychedelics " Nova Mentis (CSE:NOVA) appoints Derek Ivany as Executive Chairman Nova Mentis Life Science (NOVA) has announced the appointment of Derek Ivany to the position of Executive Chairman. Shoran Devi2 mins18 January 2023 15:00 (EST)80
Market News Psychedelics " Clearmind (CSE:CMND) adds results for a pre-clinical study for cocaine addiction treatment Clearmind Medicine (CMND) found additional pre-clinical results in its research studies of MEAI and its effect on substance use disorder. Brieanna McCutcheon2 mins17 January 2023 13:00 (EST)54
Market News Psychedelics " Optimi Health (CSE:OPTI) expands functional mushroom sales network Optimi Health (OPTI) is expanding its sales network in Canada. Jon Brown2 mins17 January 2023 11:45 (EST)106
Market News Psychedelics " Field Trip Health & Wellness (TSXV:FTHW) launches online therapy Field Trip Health & Wellness (FTHW) launched Field Trip Online Therapy, a unique approach to psychotherapy. Shoran Devi2 mins12 January 2023 11:15 (EST)82
Market News Psychedelics " First Patient dosed in Small Pharma’s (TSXV:DMT) Phase I study Small Pharma (DMT) announced that the first patient has been dosed in its Phase I study exploring intermuscular administration of SPL026. Brieanna McCutcheon2 mins09 January 2023 15:30 (EST)111
Health Care Market News Psychedelics " Clearmind Medicine (CSE:CMND) demonstrates efficacy of psychedelic-derived obesity treatment in pre-clinical trial Clearmind Medicine (CMND) has announced positive pre-clinical results demonstrating the efficacy of its drug candidate MEAI. Azuka Onwuka2 mins05 January 2023 13:00 (EST)69
Health Care Market News Psychedelics " Algernon Pharmaceuticals (CSE:AGN) announces private subsidiary and SEC filing Algernon (AGN) has formed a private subsidiary to advance its psychedelic DMT stroke program. Trevor Abes2 mins03 January 2023 11:45 (EST)142